Skip to main content
. Author manuscript; available in PMC: 2022 May 4.
Published in final edited form as: J Adolesc Health. 2018 Feb 8;62(4):417–423. doi: 10.1016/j.jadohealth.2017.10.017

Table 1.

Sample characteristics by contraceptive type among sexually active adolescent and young adult women 15–24 years, 2011–2015 National Survey of Family Growth

Overall (n = 2,018) Continuing LARC (n = 155)
%(95%CI)
New LARC (n = 95) %
(95% CI)
Moderately effective (n = 798)
%(95%CI)
Less effective (n = 489)
%(95%CI)
No contraception (n = 480)
%(95%CI)
p-Valuea
Total 6.9 (5.5–8.5) 4.4 (3.3–5.9) 43.5 (40.4–46.7) 24.3 (21.6–27.2) 20.9 (18.6–23.5)
Age (mean, SE) 20.7 (.1) 21.9 (.2) 21.0 (.2) 20.7 (.1) 20.8 (.2) 19.9 (.2) p < .001
Race/ethnicity p < .001
 Whiteb 54.6 (50.6–58.5) 46.4 (37.1–55.9) 52.4 (38.3–66.2) 64.0 (58.5–69.1) 50.3 (43.3–57.3) 43.4 (36.6–50.5)
 Blackb 14.9 (12.7–17.3) 12.2 (6.7–21.1) 19.3 (11.6–30.4) 11.9 (9.1–15.3) 16.5 (12.9–21.0) 19.1 (14.8–24.2)
 Hispanicc 21.4 (18.4–24.6) 33.8 (24.6–44.4) 18.4 (9.7–32.4) 14.9 (11.2–19.6) 23.3 (18.3–29.2) 29.0 (22.6–36.2)
 Other 9.2 (6.7–12.5) 7.6 (3.6–15.4) 9.8 (4.0–22.2) 9.2 (6.3–13.4) 9.9 (6.1–15.7) 8.6 (5.3–13.6)
Mother’s level of education p = .015
 <High school 16.5 (14.1–19.2) 19.0 (12.4–27.9) 12.6 (7.1–21.5) 11.9 (9.1–15.3) 22.3 (16.5–29.4) 19.4 (14.6–25.3)
 High school or equivalent 28.1 (25.3–31.2) 34.7 (25.2–45.6) 31.0 (18.2–47.6) 25.4 (21.2–30.0) 29.0 (22.9–36.0) 30.1 (24.5–36.4)
 Some college or higher 55.4 (51.9–58.8) 46.3 (36.0–56.9) 56.4 (41.6–70.1) 62.8 (57.8–67.4) 48.7 (41.6–55.9) 50.5 (43.3–57.6)
Insurance status p < .001
 No insurance 17.6 (14.8–20.8) 26.0 (17.1–37.4) 15.4 (7.9–27.8) 10.1 (7.9–13.0) 23.9 (18.6–30.3) 23.4 (17.2–31.0)
 Public 27.1 (23.7–30.9) 29.7 (23.1–37.2) 46.8 (31.9–62.3) 22.5 (18.3–27.4) 28.1 (22.8–34.0) 30.6 (25.3–36.4)
 Private 55.3 (51.3–59.2) 44.3 (33.8–55.3) 37.8 (24.8–52.8) 67.3 (62.0–72.2) 47.9 (41.3–54.7) 46.1 (39.6–52.7)
Usual source of care p = .002
 No usual source 19.7 (17.3–22.4) 20.4 (12.2–32.2) 15.8 (8.3–28.0) 14.4 (11.2–18.3) 24.7 (19.4–30.8) 25.7 (20.5–31.8)
 Usual source FP/community health clinic 12.5 (10.4–14.9) 18.7 (10.3–31.5) 13.6 (8.1–21.7) 10.6 (7.4–15.0) 12.6 (9.5–16.4) 14.1 (11.1–17.9)
 Usual source of care private clinic or other 67.7 (64.4–70.9) 60.9 (49.2–71.4) 70.7 (58.9–80.3) 75.0 (70.3–79.3) 62.7 (56.8–68.3) 60.1 (53.8–66.1)
Number of partners, past 12 mo p = .577
 1 partner 72.8 (69.8–75.6) 74.0 (58.9–85.0) 79.4 (62.0–90.1) 73.5 (68.8–77.8) 69.7 (64.3–74.5) 73.0 (66.4–78.8)
 2 + partners 27.2 (24.4–30.2) 26.0 (15.0–41.1) 20.6 (9.9–38.0) 26.5 (22.2–31.2) 30.3 (25.5–35.7) 27.0 (21.2–33.6)
Live birth, past year p < .001
 Yes 7.5 (5.9–9.4) 0 (N/A) 36.7 (22.8–53.2) 6.0 (4.2–8.4) 7.4 (5.2–10.4) 7.1 (4.5–11.2)
 No 92.5 (90.6–94.1) 100.0 (N/A) 63.3 (46.8–77.2) 94.0 (91.6–95.8) 92.6 (89.6–94.8) 92.9 (88.8–95.5)

% = weighted percentages; CI = confidence interval; FP = family planning; LARC = long-acting reversible contraception; mo = months; n = unweighted number; SE = standard error.

a

Overall chi-square;

b

non-Hispanic, single race;

c

includes non-Hispanic other and those reporting multiple race categories.